Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Peace Agreement or Prophetic Prelude? Analyzing the Board of Peace

Is the “Board of Peace” a Prophetic Precursor to an Israeli-Palestinian…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Iran Elevated to U.N. Leadership Role on Global Social Policy

Iran Elevated to U.N. Leadership Role on Global Social Policy The…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Vance Warns Iran of “Another Option” as Nuclear Talks Intensify

Vance Warns Iran of “Another Option” as Nuclear Talks Intensify Vice…
Read more